Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis

American Journal of Perinatology

Volumn 30, Issue 2, 2013, Pages 131-141

  Shane, Andi L ^a   Stoll, Barbara J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

epidemiology; invasive candidiasis; management; neonatal sepsis

Indexed keywords

ACUTE PHASE PROTEIN; AMINOGLYCOSIDE; AMPHOTERICIN B DEOXYCHOLATE; AMPICILLIN; ANIDULAFUNGIN; C REACTIVE PROTEIN; CD64 ANTIGEN; ECHINOCANDIN; FLUCONAZOLE; LACTOFERRIN; PENICILLIN DERIVATIVE; PROCALCITONIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGENITAL HEART DISEASE; DRUG SAFETY; ENCEPHALITIS; ENDOCARDITIS; ENTERIC FEEDING; ESCHERICHIA COLI; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; IMMUNE FUNCTION TEST; INFECTION CONTROL; INVASIVE CANDIDIASIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; ONSET AGE; OSTEOMYELITIS; PREMATURITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THROMBOCYTE COUNT; TRACHEAL ASPIRATION PROCEDURE; TREATMENT DURATION; URINE CULTURE; VAGINA FLORA; VERY LOW BIRTH WEIGHT;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTEREMIA; CANDIDEMIA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFANT, NEWBORN; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TIME FACTORS;

EID: 84874111846     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0032-1333413     Document Type: Article

References (111)

1. Tissières P., Ochoda A., Dunn-Siegrist I., et al. Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ PLoS ONE: 2012; 7 e32863
2. Wynn J. L., Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol: 2010; 37 307 337
3. Schrag S. J., Stoll B. J. Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J: 2006; 25 939 940
4. Schuchat A., Zywicki S. S., Dinsmoor M. J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics: 2000; 105 1 Pt 1 21 26
5. Tita A. T., Andrews W. W. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol: 2010; 37 339 354
6. Alexander J. M. Epidural analgesia for labor pain and its relationship to fever. Clin Perinatol: 2005; 32 777 787
7. Stoll B. J., Hansen N. I., Bell E. F., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics: 2010; 126 443 456
8. Gibbs R. S., Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol: 1991; 164 5 Pt 1 1317 1326
9. Romero R., Quintero R., Oyarzun E., et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol: 1988; 159 661 666
10. Goldenberg R. L., Andrews W. W., Goepfert A. R., et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol: 2008; 198 e1 e5
11. Weston E. J., Pondo T., Lewis M. M., et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J: 2011; 30 937 941
12. Stoll B. J., Hansen N. I., Sánchez P. J., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics: 2011; 127 817 826
13. Hornik C. P., Fort P., Clark R. H., et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev: 2012; 88 02 S69 S74
14. Lim D. V., Morales W. J., Walsh A. F., Kazanis D. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol: 1986; 23 489 492
15. Boyer K. M., Gotoff S. P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med: 1986; 314 1665 1669
16. Centers for Disease Control and Prevention Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC, 2010. MMWR: 2010; 1 36
17. Moore M. R., Schrag S. J., Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis: 2003; 3 201 213
18. Stoll B. J., Hansen N., Fanaroff A. A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics: 2002; 110 2 Pt 1 285 291
19. Glasgow T. S., Young P. C., Wallin J., et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics: 2005; 116 696 702
20. Cohen-Wolkowiez M., Moran C., Benjamin D. K., et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J: 2009; 28 1052 1056
21. Healy C. M., Baker C. J., Palazzi D. L., Campbell J. R., Edwards M. S. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol: 2012
22. Shane A. L., Hansen N. I., Stoll B. J., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics: 2012; 129 e914 e922
23. Leibovitz E. Strategies for the prevention of neonatal candidiasis. Pediatr Neonatol: 2012; 53 83 89
24. Benjamin D. K. Jr, Stoll B. J., Fanaroff A. A., et al. National Institute of Child Health and Human Development Neonatal Research Network Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics: 2006; 117 84 92
25. Kaufman D. A. Challenging issues in neonatal candidiasis. Curr Med Res Opin: 2010; 26 1769 1778
26. Benjamin D. K. Jr, Poole C., Steinbach W. J., Rowen J. L., Walsh T. J. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics: 2003; 112 3 Pt 1 634 640
27. Benjamin D. K. Jr, Stoll B. J., Gantz M. G., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics: 2010; 126 e865 e873
28. Ascher S. B., Smith P. B., Watt K., et al. Antifungal therapy and outcomes in infants with invasive Candida infections. Pediatr Infect Dis J: 2012; 31 439 443
29. Stoll B. J., Hansen N. I., Adams-Chapman I., et al. National Institute of Child Health and Human Development Neonatal Research Network Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA: 2004; 292 2357 2365
30. Ascher S. B., Smith P. B., Clark R. H., et al. Sepsis in young infants with congenital heart disease. Early Hum Dev: 2012; 88 02 S92 S97
31. Schelonka R. L., Chai M. K., Yoder B. A., Hensley D., Brockett R. M., Ascher D. P. Volume of blood required to detect common neonatal pathogens. J Pediatr: 1996; 129 275 278
32. Neal P. R., Kleiman M. B., Reynolds J. K., Allen S. D., Lemons J. A., Yu P. L. Volume of blood submitted for culture from neonates. J Clin Microbiol: 1986; 24 353 356
33. Connell T. G., Rele M., Cowley D., Buttery J. P., Curtis N. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics: 2007; 119 891 896
34. Isaacs D., Barfield C. P., Grimwood K., McPhee A. J., Minutillo C., Tudehope D. I. Australian Study Group for Neonatal Infections Systemic bacterial and fungal infections in infants in Australian neonatal units. Med J Aust: 1995; 162 198 201
35. May M., Daley A. J., Donath S., Isaacs D. Australasian Study Group for Neonatal Infections Early onset neonatal meningitis in Australia and New Zealand, 1992-2002. Arch Dis Child Fetal Neonatal Ed: 2005; 90 F324 F327
36. Stoll B. J., Hansen N., Fanaroff A. A., et al. To tap or not to tap: high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics: 2004; 113 1181 1186
37. Garges H. P., Moody M. A., Cotten C. M., et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics: 2006; 117 1094 1100
38. Wynn J. L., Tan S., Gantz M. G., et al. NICHD Neonatal Research Network Outcomes following candiduria in extremely low birth weight infants. Clin Infect Dis: 2012; 54 331 339
39. Polin R. A. Committee on Fetus and Newborn Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics: 2012; 129 1006 1015
40. Azizia M., Lloyd J., Allen M., Klein N., Peebles D. Immune status in very preterm neonates. Pediatrics: 2012; 129 e967 e974
41. Newman T. B., Puopolo K. M., Wi S., Draper D., Escobar G. J. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics: 2010; 126 903 909
42. Rozycki H. J., Stahl G. E., Baumgart S. Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis. Pediatr Infect Dis J: 1987; 6 440 442
43. Hornik C. P., Benjamin D. K., Becker K. C., et al. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J: 2012; 31 799 802
44. Hornik C. P., Benjamin D. K., Becker K. C., et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J: 2012; 31 803 807
45. Gerdes J. S. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol: 1991; 18 361 381
46. Lloyd B. W., Oto A. Normal values for mature and immature neutrophils in very preterm babies. Arch Dis Child: 1982; 57 233 235
47. Gerdes J. S., Polin R. A. Sepsis screen in neonates with evaluation of plasma fibronectin. Pediatr Infect Dis J: 1987; 6 443 446
48. Bhandari V., Wang C., Rinder C., Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics: 2008; 121 129 134
49. Streimish I., Bizzarro M., Northrup V., et al. Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J: 2012; 31 777 781
50. Guida J. D., Kunig A. M., Leef K. H., McKenzie S. E., Paul D. A. Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response? Pediatrics: 2003; 111 6 Pt 1 1411 1415
51. Manzoni P., Mostert M., Galletto P., et al. Is thrombocytopenia suggestive of organism-specific response in neonatal sepsis? Pediatr Int: 2009; 51 206 210
52. Byington C. L., Kendrick J., Sheng X. Normative cerebrospinal fluid profiles in febrile infants. J Pediatr: 2011; 158 130 134
53. Kestenbaum L. A., Ebberson J., Zorc J. J., Hodinka R. L., Shah S. S. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics: 2010; 125 257 264
54. Kanegaye J. T., Nigrovic L. E., Malley R., et al. American Academy of Pediatrics, Pediatric Emergency Medicine Collaborative Research Committee Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis. Pediatrics: 2009; 123 e967 e971
55. Smith P. B., Cotten C. M., Garges H. P., et al. A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. J Perinatol: 2006; 26 111 114
56. Shah S. S., Ebberson J., Kestenbaum L. A., Hodinka R. L., Zorc J. J. Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants. J Hosp Med: 2011; 6 22 27
57. Smith P. B., Garges H. P., Cotton C. M., Walsh T. J., Clark R. H., Benjamin D. K. Jr. Meningitis in preterm neonates: importance of cerebrospinal fluid parameters. Am J Perinatol: 2008; 25 421 426
58. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med: 1999; 340 448 454
59. Philip A. G. Response of C-reactive protein in neonatal group B streptococcal infection. Pediatr Infect Dis: 1985; 4 145 148
60. Benitz W. E., Han M. Y., Madan A., Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics: 1998; 102 E41
61. Hofer N., Zacharias E., Müller W., Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology: 2012; 102 25 36
62. Benitz W. E. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol: 2010; 37 421 438
63. Dandona P., Nix D., Wilson M. F., et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab: 1994; 79 1605 1608
64. Lapillonne A., Basson E., Monneret G., Bienvenu J., Salle B. L. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet: 1998; 351 1211 1212
65. Chiesa C., Natale F., Pascone R., et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta: 2011; 412 1053 1059
66. Raynor L. L., Saucerman J. J., Akinola M. O., Lake D. E., Moorman J. R., Fairchild K. D. Cytokine screening identifies NICU patients with Gram-negative bacteremia. Pediatr Res: 2012; 71 261 266
67. Chiesa C., Panero A., Osborn J. F., Simonetti A. F., Pacifico L. Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem: 2004; 50 279 287
68. Lim L., Rozycki H. J. Postnatal SNAP-II scores in neonatal intensive care unit patients: relationship to sepsis, necrotizing enterocolitis, and death. J Matern Fetal Neonatal Med: 2008; 21 415 419
69. Bryan C. S., John J. F. Jr, Pai M. S., Austin T. L. Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance. Am J Dis Child: 1985; 139 1086 1089
70. Manzoni P., Esposito S., Gallo E., Gastaldo L., Farina D., Principi N. Switch therapy in full-term neonates with presumed or proven bacterial infection. J Chemother: 2009; 21 68 73
71. Manzoni P., Rizzollo S., Decembrino L., et al. Recent advances in prevention of sepsis in the premature neonates in NICU. Early Hum Dev: 2011; 87 01 S31 S33
72. Bégué P., Floret D., Mallet E., et al. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis. J Antimicrob Chemother: 1984; 14 (Suppl B): 161 165
73. Pickering L., ed. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL American Academy of Pediatrics: 2012
74. Alexander V. N., Northrup V., Bizzarro M. J. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr: 2011; 159 392 397
75. Clark R. H., Gordon P., Walker W. M., Laughon M., Smith P. B., Spitzer A. R. Characteristics of patients who die of necrotizing enterocolitis. J Perinatol: 2012; 32 199 204
76. Cotton C. M. Early, prolonged use of postnatal antibiotics increased the risk of necrotising enterocolitis. Arch Dis Child Educ Pract Ed: 2010; 95 94
77. Kuppala V. S., Meinzen-Derr J., Morrow A. L., Schibler K. R. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr: 2011; 159 720 725
78. Wade K. C., Wu D., Kaufman D. A., et al. National Institute of Child Health and Development Pediatric Pharmacology Research Unit Network Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother: 2008; 52 4043 4049
79. Wade K. C., Benjamin D. K. Jr, Kaufman D. A., et al. Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants. Pediatr Infect Dis J: 2009; 28 717 723
80. Carver P. L. Micafungin. Ann Pharmacother: 2004; 38 1707 1721
81. Murdoch D., Plosker G. L. Anidulafungin. Drugs: 2004; 64 2249 2258; discussion 2259-2260
82. Smith P. B., Walsh T. J., Hope W., et al. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Pediatr Infect Dis J: 2009; 28 412 415
83. Sáez-Llorens X., Macias M., Maiya P., et al. Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age. Antimicrob Agents Chemother: 2009; 53 869 875
84. Natarajan G., Lulic-Botica M., Aranda J. V. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy. J Perinatol: 2009; 29 738 743
85. Benjamin D. K. Jr, Smith P. B., Arrieta A., et al. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther: 2010; 87 93 99
86. Chapman R. L., Faix R. G. Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J: 2000; 19 822 827
87. Linder N., Klinger G., Shalit I., et al. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J Antimicrob Chemother: 2003; 52 663 667
88. Pappas P. G., Kauffman C. A., Andes D., et al. Infectious Diseases Society of America Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis: 2009; 48 503 535
89. Brass E. P., Edwards J. E. Should the guidelines for management of central venous catheters in patients with candidemia be changed now? Clin Infect Dis: 2010; 51 304 306
90. Vasudevan C., McGuire W. Early removal versus expectant management of central venous catheters in neonates with bloodstream infection. Cochrane Database Syst Rev: 2011; 8 CD008436
91. Kaufman D., Boyle R., Hazen K. C., Patrie J. T., Robinson M., Donowitz L. G. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med: 2001; 345 1660 1666
92. Healy C. M., Campbell J. R., Zaccaria E., Baker C. J. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics: 2008; 121 703 710
93. Bertini G., Perugi S., Dani C., Filippi L., Pratesi S., Rubaltelli F. F. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants. J Pediatr: 2005; 147 162 165
94. Healy C. M., Baker C. J., Zaccaria E., Campbell J. R. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr: 2005; 147 166 171
95. Kaufman D. Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants. Pediatrics: 2008; 122 1158 1159; author reply 1159
96. Manzoni P., Stolfi I., Pugni L., et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med: 2007; 356 2483 2495
97. Uko S., Soghier L. M., Vega M., et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics: 2006; 117 1243 1252
98. Kaufman D., Fairchild K. D. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev: 2004; 17 638 680
99. Noyola D. E., Fernandez M., Moylett E. H., Baker C. J. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis: 2001; 32 1018 1023
100. Schulman J., Stricof R., Stevens T. P., et al. New York State Regional Perinatal Care Centers Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics: 2011; 127 436 444
101. Aly H., Herson V., Duncan A., et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics: 2005; 115 1513 1518
102. Del Vecchio A., Christensen R. D. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended? Early Hum Dev: 2012; 88 02 S19 S24
103. El-Ganzoury M. M., El-Farrash R. A., Saad A. A., Mohamed A. G., El-Sherbini I. G. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial. Pediatr Hematol Oncol: 2012; 29 272 284
104. Carr R., Modi N., Doré C. G-CSF. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev: 2003; 3 CD003066
105. Napolitano L. M. Immune stimulation in sepsis: to be or not to be? Chest: 2005; 127 1882 1885
106. Ohlsson A., Lacy J. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev: 2010; 3 CD001239
107. Brocklehurst P., Farrell B., King A., et al. INIS Collaborative Group Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med: 2011; 365 1201 1211
108. Morinis J., Shah J., Murthy P., Fulford M. Horizontal transmission of group B streptococcus in a neonatal intensive care unit. Paediatr Child Health (Oxford): 2011; 16 e48 e50
109. Köser C. U., Holden M. T., Ellington M. J., et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med: 2012; 366 2267 2275
110. Manzoni P., Rinaldi M., Cattani S., et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA: 2009; 302 1421 1428
111. Pammi M., Abrams S. A. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev: 2011; 10 CD007138